INSIGHTS ON CLINICAL TRIAL DESIGN

• Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads

  Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.

• Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes

  Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.

• Configuration Over Code: Why RTSM Architecture Matters Long After Go-Live

  Learn how configuration-driven RTSM architecture can simplify protocol changes, reduce operational burden, and help teams manage amendments with greater efficiency and control.

• Designing More Representative Trials Through Strategic Planning

  Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.

• Demonstrating IDS Value With Time-Based Metrics

  6/10/2026

  Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

• The Growing Complexity Of Conducting Oncology Trials

  11/17/2025

  As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.

• Why Tax Reporting Matters In Clinical Trial Participant Payments

  3/20/2026

  Clinical trial participant payments can trigger often overlooked tax reporting obligations. Learn why early visibility into payments matters and how better tracking helps avoid compliance surprises.

• Multi-Regional Clinical Trials: The Latest Guidance From FDA

  3/12/2025

  Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.

• 5 Questions To Ask Before Selecting A Randomization Partner

  5/12/2026

  Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.